What is Syneos health known for?

What is Syneos health known for?

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success. We lead with a product development mindset, strategically blending clinical development, medical affairs and commercial capabilities to address modern market realities.

Is Syneos a MNC?

INC is a CRO, which is a MNC its provide better atmosphere for work and fun with salary satisfaction.

What does inVentiv Health do?

inVentiv Health is a global professional services organization designed to help the biopharmaceutical industry accelerate the delivery of much-needed therapies to market.

Does Syneos Health give bonuses?

Overall good, salary not on market level, no bonuses.

Is inVentiv health now Syneos?

INC Research/inVentiv Health Becomes Syneos Health™ RALEIGH, N.C. – January 4, 2018 – INC Research/inVentiv Health (Nasdaq: INCR) today announced it has changed its brand identity to Syneos Health, Inc., effective January 4, 2018.

Who bought inVentiv?

Thomas H. Lee Partners
Thomas H. Lee Partners acquired inVentiv in 2010 for about $1.1 billion.

Who is the CEO of Syneos Health?

Alistair MacDonald (2016–)Syneos Health / CEO

Who is inVentiv Health?

inVentiv Health, Inc. is a leading global provider of best-in-class clinical, commercial and consulting services to companies seeking to accelerate performance. inVentiv’s client roster includes more than 550 pharmaceutical, biotech and life sciences companies.

What services does inVentiv offer for clinical trials?

For Phase IIb – III clinical trials, inVentiv Health Clinical offers a full range of services including biostatistics, data management, project management, study monitoring, patient recruitment, and global safety and pharmacovigilance.

How many shares does inVentiv Health Holdings UK Limited own?

INVENTIV HEALTH HOLDINGS UK LIMITED owns 6443914 ORDINARY shares, with a value of 1.000000 GBP each. INVENTIV HEALTH SWITZERLAND GMBH owns 13561073 ORDINARY shares, with a value of 1.000000 GBP each.

Where can I learn more about the INC Research-inVentiv Health merger?

Learn more at www.inventivhealth.com Our exciting merger with INC Research is official. Integrating our best practices and processes creates a company that is a far better fit for the modern biopharmaceutical world. And it will have one purpose: Shortening the distance from lab to life.